It’s that time again… the frantic whirl of both bid submission and material development in anticipation of the upcoming plan year and sales/enrollment activities. Here are some things to consider when developing PY2021 materials.
There’s no doubt about it: COVID-19 will change the way we sell Medicare products. Health plans must pivot strategies to navigate the new norms of COVID-19 and an upcoming Presidential election.
Declaring COVID-19 a national emergency has two major implications for Medicare Advantage plans: Allowing for a Special Enrollment Period (SEP) and the opportunity to offer new benefits.
Developing a marketing strategy during a Presidential election year is difficult enough. But adding in the current, and eventually, post-COVID-19 environment, which is unprecedented, makes it even more challenging. How can you rethink your AEP marketing strategy?
In a recent webinar presented with Deft Research, GHG shared the key lessons learned from the 2020 AEP results. Read a synopsis of what these lessons entail and watch the webinar recording on demand.
In a recent webinar, GHG shared the critical trends in supplemental benefits from the AEP results data that health plans need to know going into 2021 bids. Read a summary of the key takeaways and view the webinar recording on demand.
CMS recently broadened access and greatly relaxed regulations around telehealth services for Medicare beneficiaries. What does this mean for Medicare Advantage plans and providers?
Since COVID-19 surfaced, consumers have been bombarded with media coverage about the spread of the pandemic, most of which has been less than positive. Medicare beneficiaries are extremely vulnerable right now, and they need a voice of reason. As a health plan, you can be that voice.
With bid submissions on the horizon, CMS’ recently announced Advance Notice and Proposed Rule should be top of mind for product strategy leaders. Read our key takeaways.
January 1, 2020, Medicare Advantage (MA) enrollees have a one-time opportunity to switch their plan,…